blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2918300

EP2918300 - Syringe with disabling mechanism [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  11.06.2021
Database last updated on 31.08.2024
FormerThe patent has been granted
Status updated on  03.07.2020
FormerGrant of patent is intended
Status updated on  23.02.2020
FormerExamination is in progress
Status updated on  10.11.2017
Most recent event   Tooltip17.06.2022Lapse of the patent in a contracting state
New state(s): CY, HU, MT, TR
published on 20.07.2022  [2022/29]
Applicant(s)For all designated states
Becton, Dickinson and Company
1 Becton Drive
Franklin Lakes, NJ 07417-1880 / US
[2016/49]
Former [2015/38]For all designated states
Becton Dickinson and Company
One Becton Drive
Franklin Lakes, NJ 07417-1880 / US
Inventor(s)01 / Caizza, Richard J.
One Cherry Tree Road
NJ, 07462 Vernon / US
02 / Odell, Robert
357 Pulis Avenue
NJ, 07417 Franklin Lakes / US
03 / Wayman, Brian H.
27 Sherman Avenue
NJ, 07950 Morris Plains / US
 [2015/38]
Representative(s)dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB
Deichmannhaus am Dom
Bahnhofsvorplatz 1
50667 Köln / DE
[2020/32]
Former [2015/38]Von Kreisler Selting Werner - Partnerschaft von Patentanwälten und Rechtsanwälten mbB
Deichmannhaus am Dom
Bahnhofsvorplatz 1
50667 Köln / DE
Application number, filing date15155446.631.10.2008
[2015/38]
Priority number, dateUS2008013773212.06.2008         Original published format: US 137732
[2015/38]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2918300
Date:16.09.2015
Language:EN
[2015/38]
Type: B1 Patent specification 
No.:EP2918300
Date:05.08.2020
Language:EN
[2020/32]
Search report(s)(Supplementary) European search report - dispatched on:EP09.06.2015
ClassificationIPC:A61M5/50, A61M5/315
[2015/38]
CPC:
A61M5/502 (EP,US); A61M5/3286 (KR); A61M5/315 (KR);
A61M5/5066 (EP,US); A61M2005/31516 (EP,US); A61M2005/5026 (EP,US);
A61M2005/5073 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2016/17]
Former [2015/38]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:Spritze mit Deaktivierungsmechanismus[2015/38]
English:Syringe with disabling mechanism[2015/38]
French:Seringue avec mécanisme de neutralisation[2015/38]
Examination procedure15.03.2016Amendment by applicant (claims and/or description)
15.03.2016Examination requested  [2016/17]
14.11.2017Despatch of a communication from the examining division (Time limit: M04)
16.03.2018Reply to a communication from the examining division
24.02.2020Communication of intention to grant the patent
24.06.2020Fee for grant paid
24.06.2020Fee for publishing/printing paid
24.06.2020Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP08874649.0  / EP2318077
Opposition(s)07.05.2021No opposition filed within time limit [2021/28]
Fees paidRenewal fee
17.02.2015Renewal fee patent year 03
17.02.2015Renewal fee patent year 04
17.02.2015Renewal fee patent year 05
17.02.2015Renewal fee patent year 06
17.02.2015Renewal fee patent year 07
26.10.2015Renewal fee patent year 08
25.10.2016Renewal fee patent year 09
23.10.2017Renewal fee patent year 10
26.10.2018Renewal fee patent year 11
21.10.2019Renewal fee patent year 12
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU31.10.2008
AT05.08.2020
CY05.08.2020
CZ05.08.2020
DK05.08.2020
EE05.08.2020
FI05.08.2020
HR05.08.2020
LT05.08.2020
LV05.08.2020
MC05.08.2020
MT05.08.2020
NL05.08.2020
PL05.08.2020
RO05.08.2020
SE05.08.2020
SI05.08.2020
SK05.08.2020
TR05.08.2020
CH31.10.2020
LI31.10.2020
LU31.10.2020
BG05.11.2020
NO05.11.2020
GR06.11.2020
IS05.12.2020
PT07.12.2020
[2022/27]
Former [2021/37]AT05.08.2020
CZ05.08.2020
DK05.08.2020
EE05.08.2020
FI05.08.2020
HR05.08.2020
LT05.08.2020
LV05.08.2020
MC05.08.2020
NL05.08.2020
PL05.08.2020
RO05.08.2020
SE05.08.2020
SI05.08.2020
SK05.08.2020
CH31.10.2020
LI31.10.2020
LU31.10.2020
BG05.11.2020
NO05.11.2020
GR06.11.2020
IS05.12.2020
PT07.12.2020
Former [2021/36]AT05.08.2020
CZ05.08.2020
DK05.08.2020
EE05.08.2020
FI05.08.2020
HR05.08.2020
LT05.08.2020
LV05.08.2020
MC05.08.2020
NL05.08.2020
PL05.08.2020
RO05.08.2020
SE05.08.2020
SI05.08.2020
SK05.08.2020
LU31.10.2020
BG05.11.2020
NO05.11.2020
GR06.11.2020
IS05.12.2020
PT07.12.2020
Former [2021/31]AT05.08.2020
CZ05.08.2020
DK05.08.2020
EE05.08.2020
FI05.08.2020
HR05.08.2020
LT05.08.2020
LV05.08.2020
MC05.08.2020
NL05.08.2020
PL05.08.2020
RO05.08.2020
SE05.08.2020
SK05.08.2020
LU31.10.2020
BG05.11.2020
NO05.11.2020
GR06.11.2020
IS05.12.2020
PT07.12.2020
Former [2021/28]AT05.08.2020
CZ05.08.2020
DK05.08.2020
EE05.08.2020
FI05.08.2020
HR05.08.2020
LT05.08.2020
LV05.08.2020
NL05.08.2020
PL05.08.2020
RO05.08.2020
SE05.08.2020
SK05.08.2020
BG05.11.2020
NO05.11.2020
GR06.11.2020
IS05.12.2020
PT07.12.2020
Former [2021/22]AT05.08.2020
CZ05.08.2020
DK05.08.2020
EE05.08.2020
FI05.08.2020
HR05.08.2020
LT05.08.2020
LV05.08.2020
NL05.08.2020
PL05.08.2020
RO05.08.2020
SE05.08.2020
BG05.11.2020
NO05.11.2020
GR06.11.2020
IS05.12.2020
PT07.12.2020
Former [2021/20]AT05.08.2020
DK05.08.2020
FI05.08.2020
HR05.08.2020
LT05.08.2020
LV05.08.2020
NL05.08.2020
PL05.08.2020
SE05.08.2020
BG05.11.2020
NO05.11.2020
GR06.11.2020
IS05.12.2020
PT07.12.2020
Former [2021/12]AT05.08.2020
FI05.08.2020
HR05.08.2020
LT05.08.2020
LV05.08.2020
NL05.08.2020
PL05.08.2020
SE05.08.2020
BG05.11.2020
NO05.11.2020
GR06.11.2020
IS05.12.2020
PT07.12.2020
Former [2021/10]AT05.08.2020
FI05.08.2020
HR05.08.2020
LT05.08.2020
LV05.08.2020
PL05.08.2020
SE05.08.2020
BG05.11.2020
NO05.11.2020
GR06.11.2020
IS05.12.2020
PT07.12.2020
Former [2021/09]AT05.08.2020
FI05.08.2020
LT05.08.2020
SE05.08.2020
BG05.11.2020
NO05.11.2020
GR06.11.2020
PT07.12.2020
Former [2021/08]FI05.08.2020
LT05.08.2020
SE05.08.2020
BG05.11.2020
NO05.11.2020
PT07.12.2020
Former [2021/07]FI05.08.2020
LT05.08.2020
NO05.11.2020
Documents cited:Search[XY]WO2004045683  (DUGMORE PETER BALFOUR [ZA], et al) [X] 1 * abstract * [Y] 2-18;
 [XY]EP0340899  (FARBSTEIN DAVID [IL], et al) [X] 1 * abstract * [Y] 2-18;
 [E]WO2008154616  (BECTON DICKINSON CO [US], et al) [E] 1-18 * figures 4,6,11,16-18,26,27 *;
 [XY]WO9003818  (AGVEN MEDICAL CORP [GB]) [X] 1 * figures 1-4 * [Y] 2-18
ExaminationUS2004176722
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.